Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund trading on Cboe BZX. This page shows HELX holdings, historical performance, and technical indicators including RSI, MACD, and the 52-week price range.
Technical Analysis
RSI (14) 56.7 Neutral
Volume 92
ETF Profile
AUM $21.4M
Expense Ratio 0.50%
Holdings 61
Top Holdings
| Name | Weight | Value |
|---|---|---|
| | 6.77% | $1.5M |
| | 6.65% | $1.4M |
| | 5.32% | $1.1M |
| | 4.64% | $996,206 |
| | 4.52% | $970,000 |
| | 4.22% | $905,377 |
| | 3.53% | $757,472 |
| ASTRAZENECA PLC | 3.40% | $728,727 |
| | 3.12% | $669,640 |
| | 2.99% | $640,784 |
Other Index and Sector ETFs
Take HELX further
- Browse Index and Sector ETFs for the rest of the group, with what the businesses in it have in common and where they differ.
- Put HELX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Franklin Genomic Advancements ETF next reports.
Set alerts on HELX
Get notified when Franklin Genomic Advancements ETF hits your price targets or technical conditions are met.
Get Started Free